Matti Wahlsten (M Wahlsten)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

High Throughput Sequencing

Top Venues

ACS chemical biology

Organic & biomolecular chemistry

Chemical communications (Cambridge, England)

RSC chemical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Sıla Arsın, Maija Pollari, Endrews Delbaje, Jouni Kalevi Jokela, Matti Wahlsten, Perttu Permi, David Peter Fewer
A refactored biosynthetic pathway for the production of glycosylated microbial sunscreens. RSC chemical biology (2024)
Sıla Arsın, Endrews Delbaje, Jouni Kalevi Jokela, Matti Wahlsten, Zoë M Farrar, Perttu Permi, David Peter Fewer
A Plastic Biosynthetic Pathway for the Production of Structurally Distinct Microbial Sunscreens. ACS chemical biology (2023)
Xiaodan Ouyang, Paul M D'Agostino, Matti Wahlsten, Endrews Delbaje, Jouni Kalevi Jokela, Perttu Permi, Greta Gaiani, Antti Poso, Piia Bartos, Tobias A M Gulder, Hannu Koistinen, David Peter Fewer
Direct pathway cloning and expression of the radiosumin biosynthetic gene cluster. Organic & biomolecular chemistry (2023)
Claudia Clemente, Nicholas Johnson, Xiaodan Ouyang, Rafael Vicentini Popin, Sergio Dall'Angelo, Matti Wahlsten, Jouni Jokela, Alessandro Colombano, Brunello Nardone, David Peter Fewer, Wael E Houssen
Biochemical characterization of a cyanobactin arginine- N -prenylase from the autumnalamide biosynthetic pathway. Chemical communications (Cambridge, England) 58 (86) (2022)
Lassi Matti Petteri Heinilä, J Jokela, M N Ahmed, Matti Wahlsten, Kumar Saurav, Pavel Hrouzek, P Permi, Hannu Koistinen, David Peter Fewer, Kaarina Sivonen
Discovery of varlaxins, new aeruginosin-type inhibitors of human trypsins. Organic & biomolecular chemistry 20 (13) (2022)
Lassi Matti Petteri Heinilä, David Peter Fewer, Jouni Kalevi Jokela, Matti Wahlsten, Xiaodan Ouyang, Perttu Permi, Anna Jortikka, Kaarina Sivonen
The structure and biosynthesis of heinamides A1-A3 and B1-B5, antifungal members of the laxaphycin lipopeptide family. Organic & biomolecular chemistry 19 (25) (2022)
Tânia Keiko Shishido, Matti Wahlsten, Pia Laine, Jouko Rikkinen, Taina Kristina Lundell, Petri Auvinen
Microbial Communities of Cladonia Lichens and Their Biosynthetic Gene Clusters Potentially Encoding Natural Products. Microorganisms 9 (7) (2021)
Muhammad N Ahmed, Matti Wahlsten, Jouni Kalevi Jokela, Matthias Nees, Ulf-Håkan Stenman, Danillo Oliveira Alvarenga, Tomas Strandin, Kaarina Sivonen, Antti Poso, Perttu Permi, Mikko Metsä-Ketelä, Hannu Koistinen, David Peter Fewer
Potent Inhibitor of Human Trypsins from the Aeruginosin Family of Natural Products. ACS chemical biology 16 (11) (2021)
Antti Mattila, Rose-Marie Andsten, Mikael Jumppanen, Michele Assante, Jouni Kalevi Jokela, Matti Wahlsten, Kornelia M Mikula, Cihad Sigindere, Daniel H Kwak, Muriel Gugger, Harri Koskela, Kaarina Sivonen, Xinyu Liu, Jari T Yli-Kauhaluoma, Hideo Iwaï, David Peter Fewer
Biosynthesis of the Bis-Prenylated Alkaloids Muscoride A and B. ACS chemical biology 14 (12) (2019)
Joana Martins, Niina Leikoski, Matti Wahlsten, Joana Azevedo, Jorge Antunes, Jouni Kalevi Jokela, Kaarina Sivonen, Vitor Vasconcelos, David Peter Fewer, Pedro N Leão
Sphaerocyclamide, a prenylated cyanobactin from the cyanobacterium Sphaerospermopsis sp. LEGE 00249. Scientific reports 8 (1) (2018)
Cristina N Alexandru-Crivac, Christian Umeobika, Niina Leikoski, Jouni Kalevi Jokela, Kirstie A Rickaby, André M Grilo, Peter Sjö, Alleyn T Plowright, Mohannad Idress, Eike Siebs, Ada Nneoyi-Egbe, Matti Wahlsten, Kaarina Sivonen, Marcel Jaspars, Laurent Trembleau, David Peter Fewer, Wael E Houssen
Cyclic peptide production using a macrocyclase with enhanced substrate promiscuity and relaxed recognition determinants. Chemical communications (Cambridge, England) 53 (77) (2018)